Astellas Pharma (Astellas Pharma) 5-Year Yield-on-Cost %

: 7.93 (As of Today)

View and export this data going back to 2008. Start your Free Trial

Astellas Pharma's yield on cost for the quarter that ended in Dec. 2023 was 7.93.

The historical rank and industry rank for Astellas Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:

ALPMY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.25 Med: 3.75 Max: 7.97
Current: 7.93

During the past 13 years, Astellas Pharma's highest Yield on Cost was 7.97. The lowest was 2.25. And the median was 3.75.

ALPMY's 5-Year Yield-on-Cost % is ranked better than
87.37% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.23 vs ALPMY: 7.93

Competitive Comparison

For the Drug Manufacturers - General subindustry, Astellas Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma 5-Year Yield-on-Cost % Distribution

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's 5-Year Yield-on-Cost % falls into.

Astellas Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Astellas Pharma is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Astellas Pharma (OTCPK:ALPMY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Astellas Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.